Note 11 - Equity Compensation	3 Months Ended
Sep. 30, 2021
Notes to Financial Statements
Share-based Payment Arrangement [Text Block]	NOTE 11 – EQUITY COMPENSATION In November 2019, the Company’s shareholders approved the 2019 Omnibus Award Plan (“2019 Omnibus Plan”). The purpose of the 2019 Omnibus Plan is to provide a means through which the Company may attract and retain key personnel and to provide a means by which directors, officers, and employees can acquire and maintain an equity interest in the Company. The number of shares that remain reserved for issuance under the 2019 Omnibus Plan equates to 1,974,655 as of September 30, 2021. The 2019 Omnibus Plan implements the use of a fungible share ratio that consumes 2.5 available shares for every full value share awarded by the Company as stock compensation. The 2019 Omnibus Plan allows for the grant of stock options, stock appreciation rights, restricted stock awards, restricted stock units (“RSUs”), performance stock units (“PSUs”) and other stock-based awards. There were no equity awards granted in the three months ended September 30, 2021. Stock compensation expense was $0.6 million and $0.5 million for the three months ended September 30, 2021 and 2020, respectively.

Note 11 - Equity Compensation

3 Months Ended

Sep. 30, 2021

Share-based Payment Arrangement [Text Block]

NOTE 11 – EQUITY COMPENSATION

In November 2019, the Company’s shareholders approved the 2019 Omnibus Award Plan (“2019 Omnibus Plan”). The purpose of the 2019 Omnibus Plan is to provide a means through which the Company may attract and retain key personnel and to provide a means by which directors, officers, and employees can acquire and maintain an equity interest in the Company. The number of shares that remain reserved for issuance under the 2019 Omnibus Plan equates to 1,974,655 as of September 30, 2021. The 2019 Omnibus Plan implements the use of a fungible share ratio that consumes 2.5 available shares for every full value share awarded by the Company as stock compensation. The 2019 Omnibus Plan allows for the grant of stock options, stock appreciation rights, restricted stock awards, restricted stock units (“RSUs”), performance stock units (“PSUs”) and other stock-based awards.

There were no equity awards granted in the three months ended September 30, 2021. Stock compensation expense was $0.6 million and $0.5 million for the three months ended September 30, 2021 and 2020, respectively.